{"id":740869,"date":"2023-03-16T16:24:02","date_gmt":"2023-03-16T20:24:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/"},"modified":"2023-03-16T16:24:02","modified_gmt":"2023-03-16T20:24:02","slug":"prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/","title":{"rendered":"ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PLEASANTON, Calif., March  16, 2023  (GLOBE NEWSWIRE) &#8212; ProSomnus, Inc.\u00a0(\u201cthe Company\u201d) (NASDAQ:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ALaOvTT3-wDN3NzsixqiflyHQ0g9OLqvgWo_YYtMOmb96dIoQy3vFqNVganVQF6DrWyv2MOOH7C-n20i86vYGH_SwWpOH1yf3wwzJU21xf5FB3VjSu0saQNxan7gq4hoz67smBRgNbRxwG1DgC5blTDoQkp2HuitRoVD7mq-gKQCi9giY7CcPOpT1xzQ22mIfc7UFofpaRNTKnMVh433ps5OYpm1utAzar6rPg3BGpG458jVFz_Y3fiFubAjY4Y-0MH-VaYmNMKmcYW94uernXlu8VAnT-FNLJGgJfyqWo5MsEtKyLmCTs-Q1x-oj5dPMXzcqyQkZAhs7scRfWcT1I21I6shXln-cY09vG_gHjNSA7eZLZNd493rjf_36lR-NlLlU8QcuAhhF2zYh2ZZjA==\" rel=\"nofollow noopener\" target=\"_blank\">OSA<\/a>), the pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), will report its fourth quarter and full year 2022 financial results after market close on Thursday, March 30, 2023. ProSomnus Chief Executive Officer, Len Liptak, and Chief Financial Officer, Brian Dow, will host a conference call that day at 1:30 p.m. PT \/ 4:30 p.m. ET to discuss the reported results and provide a business update.<\/p>\n<p align=\"left\">Interested parties may register for the conference call using the following link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Cia0LgtPWi7mMTHagwQBSiKRZDm64jqdnTDW5FzosKlISmqutWs4DCgkrOaoq3ED_D7d4GyYCd7xkGZzDS7un6tCoEQ5MEJqpHnCRWyZ6ui8AxWEqNq52_dwCpdrtd6z9AL_Aixek5Zp1TpWmNqI-QJrYmBvNC9cZ0zDarg1r1Q9Q7M60cp2NqMchFNQjAoE\" rel=\"nofollow noopener\" target=\"_blank\">ProSomnus Q4 Earnings Registration Link<\/a>. You may access the live webcast of the conference call by using the following link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Cia0LgtPWi7mMTHagwQBSiKRZDm64jqdnTDW5FzosKnvGEyQ2vchv5NmJdkZYZfpb5fzbf52QaprvUtrN7FwjBmr7YjZqITdIv-XMrVfuurJ8vruRonBaUfsjLIi2FBB\" rel=\"nofollow noopener\" target=\"_blank\">ProSomnus Q4 Earnings Call<\/a>. The link will also be posted in the Investor Relations section of the ProSomnus website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VknK8jyT3GWq4sgThK8F0bIcvJp-LXw8tjF4wJ9I4P1hxZ6LoJ6JSWtxK5VCvVZloSejPjjGzprnP0l-5QdCeHO7qjtKt9SVhYLzk0h8U93avJKFVwRsLwDeGKh557VW\" rel=\"nofollow noopener\" target=\"_blank\">News &amp; Events<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About ProSomnus<\/strong><br \/>\n        <br \/>ProSomnus (NASDAQ: OSA) precision intraoral medical devices offer effective, economical, and patient-preferred treatment for patients suffering from Obstructive Sleep Apnea (OSA). ProSomnus is the first manufacturer of mass-customized Precision Oral Appliance Therapy (OAT) devices to treat OSA, which affects over 74 million people in North America and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus\u2019s patented, FDA-cleared devices are a less invasive and more comfortable alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to effective and patient-preferred outcomes. A growing body of research, including studies published by the <em>Journal of Clinical Sleep Medicine<\/em> and <em>Military Medicine<\/em>, suggests ProSomnus\u2019s Precision OAT devices are an effective treatment for mild to moderate OSA. Additional clinical research has shown that ProSomnus\u2019s Precision OAT devices mitigate many of the side effects associated with alternative treatments and improve economics for payers and providers. With more than 200,000 devices delivered, ProSomnus\u2019s devices are the most prescribed Precision OAT in the U.S. ProSomnus\u2019s FDA-cleared devices are authorized by the Department of Defense and the U.S. Army, and are often covered by medical insurance, Medicare, and social health programs in key international markets. To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=a4lSiC0e9zetLhMp53AYtPqkO1X6d-YjB1f7CL7u5lfwFTXB4cci9F3cf-UsN6tu9-zQFVVfsRtVekYjI296BXM96Lc8AOSsLY-P39LIHD4UP8WVCdXJjcxfQBL2KkQsSDxJGQu5Dvy1T_jqdq5JeJoTgqF91i94V4v3e8yy5lF0ZzuYRUFikvZYVmrCH5xgmcuStWO28gqPI1cxUO7GDJY-BTJJpsjv2kxulY2fVEc=\" rel=\"nofollow noopener\" target=\"_blank\">www.ProSomnus.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Mike Cavanaugh<br \/>ICR Westwicke<br \/>Phone: +1.617.877.9641<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FcXyCImAPIldXBOzmpXjWppTjgimctNlDIzeEZhKW0AIp3fq_MIfFn4aoyTAeeAyfMTLwqZEwyEMtmpLjs8tekDl53CORJrmFa4hzt8U5qiGGwjDlsz-0EowKMVI4S19Eo8VD67C9pTgcteMMrvCO01uZCT5JeeoRQOF71pjO1aJ6JKqJtU6ZQGFSOj33lql559E0UEDM_6hgMAIbdaBzdCOTVXnbNcS_N3w78B3P-ztrEZ3a6isHnFZJLx_bxFfA2xJUCE-kmc1L-lQicwKEGxpp6V6BV9twKooNa-ZJ5LrLcB56LPaSB9sHgkWLMCXY7FzMDTUuIPqL7GdyQeahiNM6fxrMKuKylmNmslpqFRDP-GWQ1eK6PHumZrBy19c-To1YP1IvoMIe6EyUXK1CKFfK0VZmJzBIH770XUs9WmLPOeGXGVh1mcoWAlHrTGmq9u6IG_FUjCCaQgBZdHHQ3RrdLFTvZ6_5AqsTt-OzHB_253ECiwU643-736RZ5UI2UorDhCorN1VqIT0Db4awWHooitmnw113LlMRxMGBmTRVB56QP6rZpxWHW9XTjfcWdgR4hkf6mljg6t4lvWETGUIcLSuqwctnNAazaapf7yLehLjw3vA1GmVcvkOt4ltf4cuCayja-RgNuWSFwIFnebMfznF9o0rMWJUIKwASbATUS20YBqEt031IZANgqFxvLEtn6INq6FrB_A8IcfZDAy2B883lLKmm-XRL4LFeDvvPBcF9LPPY4ahRy3b0pq7u-s48-sd8qikrK9c79cV4PhLWY9WwAEax5ivfGIXhK03vHWLoEbOuwXO4f4GoDRAzjdlr1YlOpI2XdaOsfB4aw==\" rel=\"nofollow noopener\" target=\"_blank\">Mike.Cavanaugh@westwicke.com<\/a><\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Elizabeth Coleman<br \/>ICR Westwicke<br \/>Phone: +1.203.682.4783<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4UtjSD0lMZY9ZGHa67dW5KZ_E0nU-QQ-l8tXYCBeZPey767jWPQGr6lEkJAUqaHeXf_JE-FO24k01eddqyGu-CU5o_-Z4KaycXAhdWeXmZfhGCQn3w9_tm26NeDVxA4T\" rel=\"nofollow noopener\" target=\"_blank\">Elizabeth.Coleman@westwicke.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDA1NCM1NDY2NzE5IzIyNDQ3MTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MWRjZTZiNzEtYTUxOS00ZmM5LTg1MjAtZjdjY2EzMzI4YzAyLTEyNTYyNjQ=\/tiny\/ProSomnus-Sleep-Technologies-I.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PLEASANTON, Calif., March 16, 2023 (GLOBE NEWSWIRE) &#8212; ProSomnus, Inc.\u00a0(\u201cthe Company\u201d) (NASDAQ:\u00a0OSA), the pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), will report its fourth quarter and full year 2022 financial results after market close on Thursday, March 30, 2023. ProSomnus Chief Executive Officer, Len Liptak, and Chief Financial Officer, Brian Dow, will host a conference call that day at 1:30 p.m. PT \/ 4:30 p.m. ET to discuss the reported results and provide a business update. Interested parties may register for the conference call using the following link: ProSomnus Q4 Earnings Registration Link. You may access the live webcast of the conference call by using the following link: ProSomnus Q4 Earnings Call. The link &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-740869","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PLEASANTON, Calif., March 16, 2023 (GLOBE NEWSWIRE) &#8212; ProSomnus, Inc.\u00a0(\u201cthe Company\u201d) (NASDAQ:\u00a0OSA), the pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), will report its fourth quarter and full year 2022 financial results after market close on Thursday, March 30, 2023. ProSomnus Chief Executive Officer, Len Liptak, and Chief Financial Officer, Brian Dow, will host a conference call that day at 1:30 p.m. PT \/ 4:30 p.m. ET to discuss the reported results and provide a business update. Interested parties may register for the conference call using the following link: ProSomnus Q4 Earnings Registration Link. You may access the live webcast of the conference call by using the following link: ProSomnus Q4 Earnings Call. The link &hellip; Continue reading &quot;ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-16T20:24:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDA1NCM1NDY2NzE5IzIyNDQ3MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023\",\"datePublished\":\"2023-03-16T20:24:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/\"},\"wordCount\":377,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MDA1NCM1NDY2NzE5IzIyNDQ3MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/\",\"name\":\"ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MDA1NCM1NDY2NzE5IzIyNDQ3MTE=\",\"datePublished\":\"2023-03-16T20:24:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MDA1NCM1NDY2NzE5IzIyNDQ3MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MDA1NCM1NDY2NzE5IzIyNDQ3MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/","og_locale":"en_US","og_type":"article","og_title":"ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk","og_description":"PLEASANTON, Calif., March 16, 2023 (GLOBE NEWSWIRE) &#8212; ProSomnus, Inc.\u00a0(\u201cthe Company\u201d) (NASDAQ:\u00a0OSA), the pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), will report its fourth quarter and full year 2022 financial results after market close on Thursday, March 30, 2023. ProSomnus Chief Executive Officer, Len Liptak, and Chief Financial Officer, Brian Dow, will host a conference call that day at 1:30 p.m. PT \/ 4:30 p.m. ET to discuss the reported results and provide a business update. Interested parties may register for the conference call using the following link: ProSomnus Q4 Earnings Registration Link. You may access the live webcast of the conference call by using the following link: ProSomnus Q4 Earnings Call. The link &hellip; Continue reading \"ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-16T20:24:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDA1NCM1NDY2NzE5IzIyNDQ3MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023","datePublished":"2023-03-16T20:24:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/"},"wordCount":377,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDA1NCM1NDY2NzE5IzIyNDQ3MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/","name":"ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDA1NCM1NDY2NzE5IzIyNDQ3MTE=","datePublished":"2023-03-16T20:24:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDA1NCM1NDY2NzE5IzIyNDQ3MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MDA1NCM1NDY2NzE5IzIyNDQ3MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prosomnus-to-host-investor-call-and-report-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=740869"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740869\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=740869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=740869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=740869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}